In 1H17, 23 orthopaedic companies from 11 countries received their first 510(k), according to FDA. We call your attention to these companies to assist you with identifying startups, as well as ex-U.S. companies entering the U.S. market.
Premia Spine launched its U.S. pivotal Investigational Device Exemption study of the TOPS™ posterior arthroplasty device vs. traditional lumbar fusion.
Smith & Nephew signed a 3-year partnership with Imperial College London to study meniscus function and develop techniques to treat knee injuries caused by sports.